
    
      This study is designed as a prospective, observational, non-randomized, multi-centered study
      for 12 months in duration from implantation with the subjects being used as their own
      control. The primary outcome assessment will occur at three months: however, subjects will be
      followed for one year.

      A comparison of measures within the same person from pre-treatment to post-treatment will be
      performed. Also, pre-treatment and post-treatment group means and standard deviations will be
      determined.
    
  